Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

12.5%

3 terminated/withdrawn out of 24 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

71%

17 trials in Phase 3/4

Results Transparency

43%

9 of 21 completed trials have results

Key Signals

9 with results

Enrollment Performance

Analytics

Phase 4
15(83.3%)
Phase 3
2(11.1%)
Phase 2
1(5.6%)
18Total
Phase 4(15)
Phase 3(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT02268890Phase 4Completed

A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma

Role: lead

NCT01670071Phase 4Terminated

A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia

Role: lead

NCT00766402Phase 4Terminated

An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)

Role: lead

NCT00644852Completed

Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone

Role: lead

NCT00771212Completed

Observational Study on the Patients With Pain Medications

Role: lead

NCT00642564Completed

Study on Migraine and Headache in Epileptic Patients

Role: lead

NCT00641459Completed

A Study on Behavioral and Psychological Symptoms of Dementia

Role: lead

NCT00614861Completed

Pain Satisfaction Survey

Role: lead

NCT00758160Phase 4Completed

The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Role: lead

NCT02075528Phase 4Completed

Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER

Role: collaborator

NCT00526877Phase 4Completed

An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment

Role: lead

NCT00757705Phase 4Completed

An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia

Role: lead

NCT01577186Phase 4Completed

Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)

Role: lead

NCT01577160Phase 4Completed

A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With Schizophrenia

Role: lead

NCT01627860Phase 4Completed

First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical Patients

Role: lead

NCT00744757Phase 2Completed

An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)

Role: lead

NCT00803283Phase 3Terminated

A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain

Role: lead

NCT00766675Phase 4Completed

An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia Pain

Role: lead

NCT01801436Phase 3Completed

A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma

Role: lead

NCT00752635Phase 4Completed

Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris

Role: lead